does medicare cover any glp 1 drugs GLP-1 Coverage: $50 Wegovy & Zepbound Explained What to know about Medicare

The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

On the contrary, many studies have even suggested that GIP may promote obesity

22% of those who were told by a doctor that they are overweight or obese report having used GLP-1 medications

Visit OAC's Medicare Bridge Resource Hub for practical guidance and resources to help you prepare for your pharmacy visit: #Medicare #BridgeProgram #GLP1 #OAC To view or add a comment, sign in Millions Of Older Americans Now Qualify For GLP-1s Under New Medicare Program Reuters (7/1, Prentice, Niasse) reports a Medicare program starting on Wednesday allows millions of people to qualify for GLP-1 medications for just $50 a month, bringing the highly effective drugs to people aged 65 and older at an affordable price. The 18-month CMS trial program will offer for the first time Novo Nordisks Wegovy and Eli Lillys Foundayo and Zepbound as a weight-loss treatment alone. In the past, Medicare was barred from weight-loss coverage and had paid for the drugs only when prescribed for co-conditions like cardiovascular issues and severe fatty liver disease